Long-term exposure to particulate matter on cardiovascular and respiratory diseases in low- and middle-income countries: A systematic review and meta-analysis

• Published in: Frontiers in public health Vol. 11; p. 1134341
• Main Authors: Guo, Juanmei, Chai, Guorong, Song, Xuping, Hui, Xu, Li, Zhihong, Feng, Xiaowen, Yang, Kehu
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 28.03.2023
• Subjects: Aged; Air Pollutants - analysis; cardiovascular diseases; Cardiovascular Diseases - epidemiology; Developing Countries; Disease Progression; Environmental Exposure - adverse effects; Humans; long-term exposure; low- and middle-income countries; particulate matter; Particulate Matter - adverse effects; Particulate Matter - analysis; Public Health; respiratory diseases; Respiratory Tract Diseases - epidemiology; Respiratory Tract Diseases - etiology; particulate matter; cardiovascular diseases; respiratory diseases; low- and middle-income countries; long-term exposure
• ISSN: 2296-2565; 2296-2565
• DOI: 10.3389/fpubh.2023.1134341

Long-term exposure to particulate matter (PM) has essential and profound effects on human health, but most current studies focus on high-income countries. Evidence of the correlations between PM and health effects in low- and middle-income countries (LMICs), especially the risk factor PM (particles < 1 μm in size), remains unclear. To explore the effects of long-term exposure to particulate matter on the morbidity and mortality of cardiovascular and respiratory diseases in LMICs. A systematic search was conducted in the PubMed, Web of Science, and Embase databases from inception to May 1, 2022. Cohort studies and case-control studies that examine the effects of PM , PM , and PM on the morbidity and mortality of cardiovascular and respiratory diseases in LMICs were included. Two reviewers independently selected the studies, extracted the data, and assessed the risk of bias. Outcomes were analyzed a random effects model and are reported as the relative risk (RR) with 95% CI. Of the 1,978 studies that were identified, 38 met all the eligibility criteria. The studies indicated that long-term exposure to PM , PM , and PM was associated with cardiovascular and respiratory diseases: (1) Long-term exposure to PM was associated with an increased risk of cardiovascular morbidity (RR per 1.11 μg/m , 95% CI: 1.05, 1.17) and mortality (RR per 1.10 μg/m , 95% CI: 1.06, 1.14) and was significantly associated with respiratory mortality (RR 1.31, 95% CI: 1.25, 1.38) and morbidity (RR 1.08, 95% CI: 1.02, 1.04); (2) An increased risk of respiratory mortality was observed in the elderly (65+ years) (RR 1.21, 95% CI: 1.00, 1.47) with long-term exposure to PM ; (3) Long-term exposure to PM was associated with cardiovascular morbidity (RR 1.07, 95% CI 1.01, 1.13), respiratory morbidity (RR 1.43, 95% CI: 1.21, 1.69) and respiratory mortality (RR 1.28, 95% CI 1.10, 1.49); (4) A significant association between long-term exposure to PM and cardiovascular disease was also observed. Long-term exposure to PM , PM and PM was all related to cardiovascular and respiratory disease events. PM had a greater effect than PM , especially on respiratory diseases, and the risk of respiratory mortality was significantly higher for LMICs than high-income countries. More studies are needed to confirm the effect of PM on cardiovascular and respiratory diseases.